Table 2.
Prevalence of HTLV-1 infection in patients with M. leprae.
| Study | Sample size | Prevalence (%) | 95% CI | Weight (%) |
|---|---|---|---|---|
| Verdier et al. (27) (Yemen) | 117 | 0.0 | 0.0–3.1 | 7.6 |
| Braga et al. (31) (Brazil non endemic area) | 199 | 0.0 | 0–1.8 | 7.8 |
| Tekle-Haimanot et al. (32) (Ethiopia) | 250 | 0.4 | 0–2.2 | 7.9 |
| Verdier et al. (27) (Senegal) | 227 | 0.9 | 0.1–3.1 | 7.8 |
| Glaser et al. (33) (USA) | 107 | 1.9 | 0.3–6.6 | 7.5 |
| Machado et al. (34) (Brazil) | 245 | 2.4 | 0.9–5.2 | 7.8 |
| Muneishi et al. (30) (Japan) | 844 | 8.5 | 6.7–10.6 | 8.0 |
| Kashala et al. (29) (Democratic Republic of Congo) | 57 | 8.8 | 2.9–19.3 | 7.1 |
| Milanga et al. (35) (Democratic Republic of Congo) | 57 | 8.8 | 2.9–19.3 | 7.1 |
| Verdier et al. (27) (Ivory Coast) | 319 | 9.7 | 6.7–13.5 | 7.9 |
| Verdier et al. (27) (Congo) | 830 | 9.9 | 7.9–12.1 | 8.0 |
| Verdier et al. (16) (Ivory Coast) | 109 | 13.8 | 7.9–21.7 | 7.5 |
| Lechat et al. (28) (Democratic Republic of Congo) | 377 | 37.4 | 32.5–42.5 | 7.9 |
| Total (random effects) | 3,738 | 5.9 | 2.2–11.2 | 100.0 |
Test for heterogeneity: Q = 394.1; DF = 12; p < 0.0001; I2 (95% CI) = 96.96% (95.9–97.7).